Treatment of the Face and Neck With Lower Ulthera System Energy Settings

Not Applicable

Completed

• Conditions: Skin Laxity
• Interventions: Device: Ulthera System Treatment

• Registration Number: NCT01713998
• Lead Sponsor: Ulthera, Inc

Brief Summary

Up to 60 subjects will be enrolled. Enrolled subjects will receive one Ulthera® treatment on the face and neck. Follow-up visits will occur at 90 and 180 days post-treatment. Study images will be obtained pre-treatment, immediately post-treatment, and at each follow-up visit.

Detailed Description

This trial is a prospective, single-site, double-blinded, randomized, split-face design. Subjects will be randomized to one of three treatment groups, receiving treatment using different energy levels. Global Aesthetic Improvement Scale scores and patient satisfaction questionnaires will be obtained.

Study Timeline

• Study Start: 2011-09
• Primary Completion: 2012-06
• Study Completion: 2012-10
• Study First Submitted: 2012-10-15
• Study First Submitted QC: 2012-10-22
• Study First Posted: 2012-10-25
• Results First Submitted: 2013-06-19
• Results First Submitted QC: 2014-01-06
• Results First Posted: 2014-02-21
• Status Verified: 2017-11
• Last Update Submitted: 2017-11-10
• Last Update Posted: 2017-12-11

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 47

Inclusion Criteria

• Male or female, age 30 to 65 years.
• Subject in good health.
• Skin laxity on the face and neck

Exclusion Criteria

• Presence of an active systemic or local skin disease that may affect wound healing.
• Severe solar elastosis.
• Excessive subcutaneous fat in the face or neck.
• Excessive skin laxity on the face or neck.
• Significant scarring in areas to be treated.
• Open wounds or lesions in the area to be treated.
• Severe or cystic acne on the area to be treated.

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: PARALLEL

Arm && Interventions

Group	Intervention	Description
Group C	Ulthera System Treatment	Subjects will receive an increased density guideline Ulthera System Treatment over the full face with the exception that a 4 MHz transducer will be used on the upper face in place of a7 MHz transducer, with the energy turned down to the lowest level of four possible energy settings.
Group A	Ulthera System Treatment	Subjects will receive an increased density Ulthera System Treatment over the full face but with the energy turned down to the second highest level of four possible energy settings on one side of the face.
Group B	Ulthera System Treatment	Subjects will receive an increased density guideline Ulthera System Treatment over the full face but with the energy turned down to the lowest level of four possible energy settings on one side of the face.

Primary Outcome Measures

Name	Time	Method
Subjects' Assessment of Pain During Treatment With Lower Energy Settings	Participants were assessed for the duration of study treatment, an average of 75 minutes	Subjects' sensory response to the Ulthera treatment exposures were recorded using a validated Numeric Rating Scale (NRS,0-10), for each anatomical region treated and energy settings used, with 0 representing no pain and 10 representing the worst pain possible.; Pain scores were collected in a consistent manner, following treatment of each section of the face and neck on both sides (submental, submandibular, cheek, periorbital, infraorbital, and forehead), and for each transducer used. Split-face comparisons of pain scores obtained during study treatment by research staff blinded to the energy settings used were completed.
Overall Improvement in Skin Laxity on the Face and Neck	90 days post-treatment	A split-face comparison of improvement in overall lifting and tightening of skin was completed by three masked assessors. Pre-treatment and 90 days post-treatment photos from 45 subjects who returned for their 90-day follow-up visit were reviewed, assessing for improvement in skin laxity, i.e., lifted and tightened skin in the areas treated using treatment energy settings based on subjects' assigned study group.

Secondary Outcome Measures

Name	Time	Method
Subject Assessment of Improvement at 90 Days Post-treatment	90 days post-treatment	Subjects completed a Patient Assessment Questionnaire at 90 days post-treatment by referring to their image in a mirror, their 90-day post-treatment photos, and their pre-treatment photos, and reporting if any improvement was noted on the right and left sides of their face and neck.
Subject Assessment of Improvement at 180 Days Post-treatment	180 days post-treatment	Subjects completed a Patient Assessment Questionnaire at 180 days post-treatment by referring to their image in a mirror, their 180-day post-treatment photos, and their pre-treatment photos, and reporting if any improvement was noted on the right and left sides of their face and neck.
Quantitative Assessment of Brow Lift at 90 Days Post-treatment	90 days post-treatment	Quantitative assessment and analysis of brow lift from baseline to 90 days post-treatment was completed comparing brow lift achieved using standard energy settings compared to adjusted energy settings. The number of subjects with 1 mm or more brow lift is reported. Note: Because the submental region was treated using standard energy settings in all study groups, a quantitative analysis of lift in this region between the study groups would most likely not be informative, and therefore was not completed.

Trial Locations

Locations (1)

Ulthera, Inc.; 🇺🇸 Mesa, Arizona, United States